IGLV3-1

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, IGLV3-1 mutation is significantly associated with the immune_cell of many other genes, with 4 significant associations in total. DLBC shows the largest number of these associations.

The most reproducible IGLV3-1-associated genes across cancer lineages are lymphatic Endothelial cells, mv Endothelial cells, and pro B-cells. Each is linked with IGLV3-1 in more than 1 cancer types. Because this analysis shows association rather than direction, both IGLV3-1-to-partner and partner-to-IGLV3-1 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (IGLV3-1→partner) and Y-score (partner→IGLV3-1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
DLBClymphatic Endothelial cells →-0.020-3.082.027.00631
DLBCmv Endothelial cells →-0.038-3.321.002.00231
DLBCpro B-cells →+0.205+2.646<.001.00131
DLBCCD4+ naive T-cells →-0.060-2.758.037.01431
Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

Exploration